Tech Company Financing Transactions
MARAbio Funding Round
MARAbio, based in Salt Lake City, received $19 million in funding from MAK Capital and private investors.
Transaction Overview
Company Name
Announced On
10/8/2024
Transaction Type
Venture Equity
Amount
$19,000,000
Round
Series A
Investors
MAK Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support commercial launch of its autism test in 2025 and development of therapeutic interventions.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
26 S Rio Grande St. 2072
Salt Lake City, UT 84101
USA
Salt Lake City, UT 84101
USA
Phone
Undisclosed
Website
Email Address
Overview
MARAbio Systems, Inc. (MARAbio) is a precision immunology company that has exclusive rights to key discoveries made by Dr. Judy Van de Water at UC Davis / MIND Institute that form the biological basis of Maternal Autoantibody Related Autism (MARA). Our mission is to detect and mitigate Maternal Autoantibody Related Autism (MARA), a subtype that has been shown to be associated with more severe or profound forms of autism.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Paul
Chief Medical Officer
Robert Wassman
Chief Scientific Officer
Judy Van de Water
Chief Scientific Officer
James Woody
Browse more venture capital transactions:
Prev: 10/8/2024: Meridian Innovation venture capital transaction
Next: 10/8/2024: Singulate venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs